Form 4: T2 Biosystems Director Receives 25,000 Restricted Stock Units
SEC Form 4
Seymour Liebman, a director at T2 Biosystems, was granted 25,000 restricted stock units (RSUs) that vest in two equal annual installments.
Summary
- Seymour Liebman, a director of T2 Biosystems, received 25,000 restricted stock units (RSUs) on November 4, 2024.
- These RSUs will vest in two equal annual installments, starting on November 4, 2025.
- The grant was contingent on stockholder approval of the amendment and restatement of the company's 2014 Incentive Award Plan.
- Stockholder approval for the plan amendment was obtained on December 30, 2024.
- Each RSU represents the right to receive one share of T2 Biosystems common stock.
Sentiment
Score: 7
Explanation: The document reflects a standard corporate practice of granting equity compensation to directors, which is generally viewed positively as it aligns interests with shareholders. There are no indications of negative sentiment.
Positives
- The grant of RSUs to a director aligns their interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the director.
- Stockholder approval of the incentive plan amendment demonstrates shareholder support for the company's compensation strategy.
Industry Context
This is a standard practice for incentivizing directors in publicly traded companies, aligning their interests with shareholders through equity-based compensation.
Comparison to Industry Standards
- Granting restricted stock units to directors is a common practice among publicly listed companies to align their interests with shareholders.
- The vesting schedule of two equal annual installments is also a typical approach to ensure long-term commitment.
- Many companies in the biotech and medical device sector use similar equity-based compensation plans for their directors and executives.
Stakeholder Impact
- Shareholders may view the RSU grant positively as it aligns director interests with company performance.
- The vesting schedule encourages long-term commitment from the director.
Key Dates
| Date | Description |
|---|---|
| 11/04/2024 | Date of the RSU grant to Seymour Liebman. |
| 11/04/2025 | First vesting date for half of the granted RSUs. |
| 12/30/2024 | Date of stockholder approval for the amendment and restatement of the 2014 Incentive Award Plan. |
| 01/02/2025 | Date of the filing of the SEC Form 4. |
Keywords
Restricted Stock Units, RSU, Director Compensation, Incentive Award Plan, Stockholder Approval, T2 Biosystems, Seymour Liebman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.